CF
ORIC icon

Corebridge Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Corebridge Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,163
Closed -$168K – 1932
2025
Q1 		$168K Sell
30,163
-447
-1% -$3.91K ﹤0.01% 2168
2024
Q4 		$247K Sell
30,610
-2,311
-7% -$21.2K ﹤0.01% 2055
2024
Q3 		$337K Sell
32,921
-203
-0.6% -$2.01K ﹤0.01% 1931
2024
Q2 		$234K Buy
+33,124
New +$297K ﹤0.01% 2094

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Corebridge Financial's ORIC Position: Q2 2025 in Review

Corebridge Financial sold out of Oric Pharmaceuticals (ORIC) in Q2 2025, closing a stake of 30,163 shares — an estimated $168K sold.

Corebridge Financial first reported a position in ORIC in Q2 2024 and held it in 4 quarters. The position peaked at $337K in Q3 2024. 142 funds tracked by Wall St. Rank hold ORIC as of Q2 2025.

  • Corebridge Financial reported no remaining Oric Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 30,163 Oric Pharmaceuticals shares in Q2 2025, an estimated $168K.
  • Corebridge Financial first reported a position in Oric Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Oric Pharmaceuticals position peaked at $337K in Q3 2024.
  • 142 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.